MktsMarkets

Pacific Biosciences of California, Inc.
NASDAQ: PACBKey statistics
PACB News
Stories mentioning PACB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 37,178 | (115,360) | 38,441 | 39,766 | 37,153 | (114,790) | 39,967 | 36,013 |
| Cost of Goods Sold | 24,337 | 28,079 | 22,540 | 25,082 | 38,524 | 29,166 | 29,963 | 30,075 |
| Gross Profit | 12,841 | 16,566 | 15,901 | 14,684 | (1,371) | 10,058 | 10,004 | 5,938 |
| Operating Expenses | ||||||||
| Research & Development | 19,608 | 22,879 | 22,846 | 22,529 | 29,053 | 27,466 | 25,516 | 38,485 |
| Sales General & Admin | 31,153 | 34,051 | 31,099 | 36,175 | 40,168 | 41,641 | 43,746 | 45,877 |
| Total Operating Expenses | 21,198 | 57,763 | 54,778 | 59,537 | 427,563 | 163,086 | 74,081 | 181,784 |
| Operating Income (Loss) | (8,357) | (41,197) | (38,877) | (44,853) | (428,934) | (153,028) | (64,077) | (175,846) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 2,006 | 2,768 | 2,999 | 4,696 | 4,294 | 4,065 | 6,890 | 6,069 |
| Pretax Income | (8,091) | (40,169) | (37,617) | (41,895) | (426,377) | 2,687 | (60,725) | (173,319) |
| Tax Provision | 184.00 | 202.00 | 383.00 | 35.00 | (302.00) | 316.00 | 0.00 | 0.00 |
| Net Income (Loss) | (8,275) | (40,371) | (38,000) | (41,930) | (426,075) | 2,371 | (60,725) | (173,319) |
| Earnings Per Share (Basic) | (0.03) | (0.13) | (0.13) | (0.14) | (1.44) | 0.01 | (0.22) | (0.64) |
| Earnings Per Share (Diluted) | (0.03) | (0.13) | (0.13) | (0.14) | (1.44) | 0.01 | (0.22) | (0.64) |
| Weighted Average Shares Outstanding (Basic) | 305,819 | 299,959 | 300,844 | 300,162 | 296,858 | 274,488 | 272,915 | 272,385 |
| Weighted Average Shares Outstanding (Diluted) | 305,819 | 299,959 | 300,844 | 300,162 | 296,858 | 288,366 | 272,915 | 272,385 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PACB
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a stock listed on the Nasdaq Stock Market under the ticker symbol PACB. It last traded at $1.73 (Oct 16, 2026, 4:00 PM ET), down 11.7% on the day. That gives Pacific Biosciences of California a market capitalisation of $609.2M.
Over the past 52 weeks PACB has traded between $1.07 and $3.44.
Revenue for the quarter ended Mar 31, 2026 was $37.2M; a net loss of $8.3M. Revenue was up 0.1% from $37.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $37.2M | -$8.3M | -22.3% |
| Dec 31, 2025 | -$115.4M | -$40.4M | — |
| Sep 30, 2025 | $38.4M | -$38.0M | -98.9% |
| Jun 30, 2025 | $39.8M | -$41.9M | -105.4% |
From Pacific Biosciences of California’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…